Please login to the form below

Not currently logged in
Email:
Password:

Europe

This page shows the latest Europe news and features for those working in and with pharma, biotech and healthcare.

Sanofi sells European generics to Advent for $2.4bn

Sanofi sells European generics to Advent for $2.4bn

Sanofi’s total generics sales fell 3.3% to 1.78bn last year, with the declines most apparent in Europe and emerging markets.

Latest news

More from news
Approximately 52 fully matching, plus 1,246 partially matching documents found.

Latest Intelligence

  • No incentive for a cure No incentive for a cure

    curative therapies. Current healthcare systems raise several barriers. The situation is made more challenging by the range of different healthcare systems and reimbursement schemes across Europe, from social insurance systems in

  • The threat of antimicrobial resistance The threat of antimicrobial resistance

    Colistin is considered the last line of defence against multidrug-resistant organisms and using it as an animal feed supplement is unacceptable and is already banned in China and Europe.

  • Brexit Means Brexit Brexit Means Brexit

    These common-sense ambitions are broadly aligned with those of EFPIA and pharmaceutical companies across Europe. ... There’s a mature market for outsourced regulatory affairs in Europe so companies can make resourcing decisions closer to March 2019 and

  • Six degrees of participation Six degrees of participation

    But in Europe, pharma finds itself in an uncomfortable position: everyone is talking about patients yet talking to them is incredibly difficult. ... We hear some amazing, real-life stories of empowerment - but one wonders how many are applicable to the

  • Speech therapy Speech therapy

    As part of a wider focus on global patient attitudes towards artificial intelligence in health, we asked over 650 patients across Europe with an average age of 56 about their current

More from intelligence
Approximately 17 fully matching, plus 269 partially matching documents found.

Latest appointments

  • Sobi poaches Pfizer’s Fredrick Wetterlundh Sobi poaches Pfizer’s Fredrick Wetterlundh

    Joining from pharma giant Pfizer, Wetterlundh most recently held the position of global human resources lead, gaining extensive experience in leading business-driven HR organisations, processes and projects in Asia, Europe,

  • Novo Nordisk appoints new general manager Novo Nordisk appoints new general manager

    Sahota, who brings experience from business, commercial and leadership roles to Novo, was most recently responsible for creating commercial and market development strategies across Europe as senior vice president of market ... Matt Regan, senior vice

  • Ipsen bolsters leadership team Ipsen bolsters leadership team

    Prior to his time at Staples, Mulot has held HR leadership positions with Levi Strauss &Co and technology start-up Broadnet Europe.

  • Hansa Medical poaches Vifor Pharma’s CEO Hansa Medical poaches Vifor Pharma’s CEO

    operations and teams both in Europe and the US.”.

  • Amryt Pharma appoints Jordi Casals as head of Europe Amryt Pharma appoints Jordi Casals as head of Europe

    Amryt Pharma appoints Jordi Casals as head of Europe. He joins the company from Aegerion Pharmaceuticals. ... Prior to this, he worked for eight years at Alexion Pharmaceuticals, latterly as vice president commercial operations, Western Europe.

More from appointments
Approximately 3 fully matching, plus 258 partially matching documents found.

Latest from PMHub

  • Lexington Health

    We have coordinated various campaigns not only in Europe but have also coordinated projects spanning different continents.

  • Infographic: CEE

    Infographic: CEE. The Central and Eastern Europe region is home to over 145 million people and is a key global growth region.

  • Why patient education is important in oncology

    Why patient education is important in oncology. We talked to Dr Bettina Ryll of Melanoma Patient Network Europe about changes in melanoma treatment and how the added complexity of new treatments ... Therefore, the Melanoma Patient Network Europe has a

  • Biosimilars - the Brexit of the pharmaceutical industry?

    Biosimilars - the Brexit of the pharmaceutical industry? In this article, Senior Consultant Jenna Earl explains what factors influence the uptake of biosimilars in the UK, comparing them to the same principles that help us navigate the complexities

  • Fabio Lodo

    His experience in Chinese medicine comes through a residency program focused on internal medicine, a daily clinical practice and its constant updates in Europe, China and the United States.

More from PMHub
Approximately 5 fully matching, plus 286 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Just::Health Communications

Just:: is a different kind of healthcare communications agency. Since 2006, we’ve been collaborating with clients around the world to...

Latest intelligence

No incentive for a cure
The paradox of ‘cost-effective but unaffordable’ life-saving medicines...
Why heading online for scientific meetings can yield greater HCP engagement
Modern conferencing methods, with enhanced digital information transfers, offer unique opportunities for greater HCP engagement....
The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...

Infographics